Blockman, MCohen, KDe Waal, RGray, AKredo, TNel, JParrish, ARees, HReubenson, G2024-10-042024-10-042021-11-19https://www.health.gov.za/wp-content/uploads/2021/12/Rapid-review-of-Colchicine-for-COVID-19-Update_19November2021.pdfhttps://hdl.handle.net/11288/597808Colchicine, an oral anti-inflammatory drug used to treat gout, has been proposed as a potential treatment for COVID-19.Its mechanisms of action include inhibition of neutrophil and monocyte recruitment, and inhibition of proinflammatory cytokines, both of which are thought to be important mediators of COVID-19 disease severity.en-USAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/ColchicineAnti-inflammatory drugRapid reviewTreatment for COVID-19Technical Report